Serial tumor biopsies obtained in TBCRC 001 showed that the EGFR pathway was activated in most of these tumors, but the signaling was ineffective in some tumors, and there were alternative pathways to keep signaling intact despite EGFR inhibition in others79. This evidence concerns the gene EGFR and neoplasm.